In today's interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we're tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by everyone, anytime, everywhere.
Location: United States, California, San Francisco
Employees: 51-200
Total raised: $38M
Founded date: 2014
Investors 5
| Date | Name | Website |
| - | Black Diam... | bdventures... |
| 07.06.2021 | 3E Biovent... | 3ebiovc.co... |
| - | Civilizati... | civilizati... |
| 17.07.2025 | Supply Cha... | supplychan... |
| - | Celesta Ca... | celesta.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.01.2018 | Series A | $38M | - |
Mentions in press and media 6
| Date | Title | Description |
| 18.02.2025 | California’s H5N1 Emergency Declaration Highlights Need for an Urgent National Response to Avian Flu | Shaun Holt, CEO of Alveo Technologies The H5N1 virus is spreading so rapidly among cattle in California that Gavin Newsom declared a state of emergency. Sick cattle not only produce less milk, but their milk is also infected with the virus,... |
| 26.10.2023 | The Week in AgriFoodTech: URB-E pivots to last-mile delivery, GoodBytz bags $12m, a new fund for regen ag | This week, URB-E, a company best known for developing e-scooters, took a sharp left turn with both its business and its brand. And while funding rounds are low and slow of late, they nonetheless trickle in despite the tough economic times. ... |
| 10.07.2020 | Bob Goeltz bolts Unity Biotechnology to become CFO at Arcus Biosciences; John Johnson tapped for his latest CEO gig | Bob Goeltz → A press release earlier in the week noted that Bob Goeltz left his CFO post at Unity Biotechnology “to pursue a new opportunity.” We now know what that opportunity is, joining Terry Rosen’s crew at Arcus Bio... |
| 30.04.2020 | Alveo partners with Johnson & Johnson to develop in-home COVID-19 testing | Johnson & Johnson will help support Alveo through its clinical trials and FDA approvals [Editor's note: Future of Behavioral and Mental Health with BetterHelp, Headspace, Ginger.io, Providence Hospitals, UnitedHealthcare Optum, Khosla V... |
| 08.01.2018 | Alveo Closes $38M in Series A Financing | Alveo Technologies, Inc., a San Francisco, CA-based maker of affordable and accessible infectious disease diagnostic devices, closed a $38m Series A financing. The round was led by Maxim Merchant Capital, a division of Maxim Group LLC, and ... |
| 04.01.2018 | Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices | A recent article on Alveo Technologies $38M Series A – Read the full article |